582 related articles for article (PubMed ID: 11967816)
21. Plasma pro-brain natriuretic peptides are strong biochemical markers in clinical cardiology.
Gøtze JP; Kastrup J
Scand J Clin Lab Invest Suppl; 2001; 234():47-51. PubMed ID: 11713980
[TBL] [Abstract][Full Text] [Related]
22. [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels].
Lindstedt G; Dahlström U; Fernlund P; Schaufelberger M; Stridsberg M
Lakartidningen; 2001 Oct; 98(41):4444-8, 4450-2. PubMed ID: 11699251
[TBL] [Abstract][Full Text] [Related]
23. [Comparison study on diagnostic and prognostic value of N-terminal pro-brain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
Li YJ; Wang L; Chen KY; Chen YL; Cai JR; Zhou LJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Sep; 17(9):544-7. PubMed ID: 16146600
[TBL] [Abstract][Full Text] [Related]
24. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
Pfister R; Tan D; Thekkanal J; Erdmann E; Schneider CA
Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
[TBL] [Abstract][Full Text] [Related]
25. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer?
Vesely DL
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic and prognostic impact of brain natriuretic peptide in cardiac and noncardiac diseases.
Zakynthinos E; Kiropoulos T; Gourgoulianis K; Filippatos G
Heart Lung; 2008; 37(4):275-85. PubMed ID: 18620103
[TBL] [Abstract][Full Text] [Related]
27. Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men.
Ohba H; Takada H; Musha H; Nagashima J; Mori N; Awaya T; Omiya K; Murayama M
Am Heart J; 2001 May; 141(5):751-8. PubMed ID: 11320362
[TBL] [Abstract][Full Text] [Related]
28. [Natriuretic peptides: physiological, pathophysiological and clinical aspects].
Michels P; Tarnow J
Anasthesiol Intensivmed Notfallmed Schmerzther; 2001 Jul; 36(7):406-16. PubMed ID: 11496615
[TBL] [Abstract][Full Text] [Related]
29. Clinical impression of brain natriuretic peptide levels in demented patients without cardiovascular disease.
Naito J; Naka Y; Watanabe H
Geriatr Gerontol Int; 2009 Sep; 9(3):242-5. PubMed ID: 19702933
[TBL] [Abstract][Full Text] [Related]
30. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction.
Richards AM; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton C; Turner J; Crozier IG; Yandle TG
Circulation; 2003 Jun; 107(22):2786-92. PubMed ID: 12771003
[TBL] [Abstract][Full Text] [Related]
31. Atrial natriuretic peptides in heart failure: pathophysiological significance, diagnostic and prognostic value.
Ghosh N; Haddad H
Can J Physiol Pharmacol; 2011 Aug; 89(8):587-91. PubMed ID: 21806511
[TBL] [Abstract][Full Text] [Related]
32. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.
Pedersen EB; Bacevicius E; Bech JN; Solling K; Pedersen HB
Clin Sci (Lond); 2006 Apr; 110(4):491-501. PubMed ID: 16396628
[TBL] [Abstract][Full Text] [Related]
33. Impact of obesity on plasma natriuretic peptide levels.
Wang TJ; Larson MG; Levy D; Benjamin EJ; Leip EP; Wilson PW; Vasan RS
Circulation; 2004 Feb; 109(5):594-600. PubMed ID: 14769680
[TBL] [Abstract][Full Text] [Related]
34. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
Stoupakis G; Klapholz M
Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
[TBL] [Abstract][Full Text] [Related]
35. [Comparison study on diagnostic and prognostic value of N-terminal probrain natriuretic peptide and atrium natriuretic peptide in chronic congestive heart failure].
Dong H; Chen DQ; Wang Y; Li M
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1740-2. PubMed ID: 18819908
[TBL] [Abstract][Full Text] [Related]
36. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
[TBL] [Abstract][Full Text] [Related]
37. Elevated levels of natriuretic peptides in patients with pulmonary thromboembolism.
Kiely DG; Kennedy NS; Pirzada O; Batchelor SA; Struthers AD; Lipworth BJ
Respir Med; 2005 Oct; 99(10):1286-91. PubMed ID: 16099151
[TBL] [Abstract][Full Text] [Related]
38. Natriuretic peptides in relation to the cardiac innervation and conduction system.
Hansson M
Microsc Res Tech; 2002 Sep; 58(5):378-86. PubMed ID: 12226807
[TBL] [Abstract][Full Text] [Related]
39. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation.
Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T
Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125
[TBL] [Abstract][Full Text] [Related]
40. Prolonged stability of brain natriuretic peptide: importance for non-invasive assessment of cardiac function in clinical practice.
Buckley MG; Marcus NJ; Yacoub MH; Singer DR
Clin Sci (Lond); 1998 Sep; 95(3):235-9. PubMed ID: 9730841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
